Pannu Bibek S, Apala Dinesh R, Kotecha Aditya, Boland Jennifer M, Iyer Vivek N
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, United States.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States.
Respir Med Case Rep. 2017 Jan 18;20:113-115. doi: 10.1016/j.rmcr.2017.01.010. eCollection 2017.
Multifocal micronodular pneumocyte hyperplasia (MMPH) is rare entity seen mostly in patients with the tuberous sclerosis complex (TSC). We present the case of a 50 year old woman with TSC (confirmed mutation) found to have multiple ground glass opacities with an upper lobe predominance on a screening chest CT. No abnormalities were detected in other viscera. A thoracoscopic lung biopsy obtained from right upper lobe confirmed the diagnosis of MMPH. There were no lesions suggestive of lymphangioleiomyomatosis (LAM) either on the chest CT or lung biopsy. A repeat CT chest obtained on follow up 9 years after initial diagnosis continued to show stability of all MMPH ground glass lesions. This case highlights the distinct patterns of lung involvement in TSC, with MMPH having a benign and stable nature as compared to LAM which is often relentlessly progressive with associated lung function decline.
多灶性微小结节性肺细胞增生症(MMPH)是一种罕见病症,多见于结节性硬化症(TSC)患者。我们报告一例50岁患有TSC(已证实有突变)的女性病例,其在胸部CT筛查时发现多个磨玻璃影,以上叶为主。其他内脏未检测到异常。经胸腔镜从右上叶获取的肺活检确诊为MMPH。胸部CT或肺活检均未发现提示淋巴管平滑肌瘤病(LAM)的病变。初次诊断9年后随访时复查胸部CT,所有MMPH磨玻璃病变仍保持稳定。该病例突出了TSC肺部受累的不同模式,与往往会持续进展并伴有肺功能下降的LAM相比,MMPH具有良性和稳定的特性。